hepatocellular carcinoma

Open Access
Spot Scanning Proton Beam Therapy for Surgery-inaccessible Hepatocellular Carcinoma: Preliminary Results
YUTAKA FUJIMOTO, SACHIKA SHIRAISHI, MASASHI YAMANAKA, AKIHIRO YAMANO, KAZUKI MATSUMOTO, SHINTARO SHIBA, TOSHITAKA TSUKIYAMA, MASAHIRO KOBAYASHI and KOICHI TOKUUYE

In Vivo May 2025, 39 (3) 1654-1660; DOI: https://doi.org/10.21873/invivo.13966
Open Access
Partial Splenic Embolization for Portal Hypertension Exacerbation During Atezolizumab/Bevacizumab Combination Therapy in Unresectable Hepatocellular Carcinoma
TORU ISHIKAWA, NANAKO TERAI, RYO SATO, HIROKI NATSUI, TAKAHIRO IWASAWA, MASAHIRO OGAWA, YUJI KOBAYASHI, TOSHIFUMI SATO, JUNJI YOKOYAMA, AKIHIKO IIDUKA and TERASU HONMA

In Vivo March 2025, 39 (2) 936-941; DOI: https://doi.org/10.21873/invivo.13898
Open Access
WNT/β-catenin Signaling and CD8+ Tumor-infiltrating Lymphocytes in Tremelimumab Plus Durvalumab for Advanced Hepatocellular Carcinoma
AKIFUMI KUWANO, KOSUKE TANAKA, JUNRO TAKAHIRA, HIDEO SUZUKI, YOSHIHIRO OHISHI and KENTA MOTOMURA

In Vivo November 2024, 38 (6) 2774-2781; DOI: https://doi.org/10.21873/invivo.13757
Open Access
Sarcopenia’s Impact Defined by Grip Strength and Muscle Mass on Post-hepatectomy Outcomes: A Multicenter Analysis
SOTARO FUKUHARA, TSUYOSHI KOBAYASHI, MICHINORI HAMAOKA, HONMYO NARUHIKO, KOICHI OISHI, YOSUKE NAMBA, KO OSHITA, KEISO MATSUBARA, DAISUKE TAKEI, RYOSUKE NAKANO, HIROSHI SAKAI, SHINTARO KURODA, HIROYUKI TAHARA, MASAHIRO OHIRA and HIDEKI OHDAN

In Vivo November 2024, 38 (6) 2827-2835; DOI: https://doi.org/10.21873/invivo.13763
Open Access
Cytoplasmic Expression of the EGFL6 Protein Is an Independent Prognostic Factor for Shortened Patient Survival in Human Hepatocellular Carcinoma
HUI-TING HSU, YUEH-MIN LIN, MING-TAI HSING, KUN-TU YEH, JENG-WEI LU and SHUN-FA YANG

In Vivo September 2024, 38 (5) 2455-2463; DOI: https://doi.org/10.21873/invivo.13715
Open Access
Determinants of Survival of Ablation Treatment for Portal Vein Tumor Thrombus in Patients With Hepatocellular Carcinoma
TORU ISHIKAWA, RYO SATO, RYO JIMBO, YUJI KOBAYASHI, TOSHIFUMI SATO, AKITO IWANAGA, TOMOE SANO, JUNJI YOKOYAMA and TERASU HONMA

In Vivo September 2024, 38 (5) 2501-2505; DOI: https://doi.org/10.21873/invivo.13721
Open Access
Similar Efficacy Between Atezolizumab Plus Bevacizumab Versus Hepatic Arterial Infusion Chemotherapy For Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Retrospective Cohort Study
AKIFUMI KUWANO, MASAYOSHI YADA, KOSUKE TANAKA, YUTA KOGA, SHIGEHIRO NAGASAWA, AKIHIDE MASUMOTO and KENTA MOTOMURA

In Vivo July 2024, 38 (4) 1854-1858; DOI: https://doi.org/10.21873/invivo.13639
Open Access
Clinicopathologic Significance of Quaking Expression in Hepatocellular Carcinoma
SUNG-EUN KIM, CHEOL KEUN PARK, JI WON PARK, JUNG WOO LEE, JI-YOUNG CHOE and YOON AH CHO

In Vivo July 2024, 38 (4) 2064-2073; DOI: https://doi.org/10.21873/invivo.13665
Open Access
Proton-beam Therapy for Locally Advanced Hepatocellular Carcinoma With Inferior Vena Cava Tumor Thrombus: Case Report
SHINTARO SHIBA, SACHIKA SHIRAISHI, KOICHI TOKUUYE, RYOSUKE SHIRATA and MOTOKO OMURA

In Vivo July 2024, 38 (4) 2080-2084; DOI: https://doi.org/10.21873/invivo.13667
Open Access
Correlation Between Low Cytoplasmic Expression of XBP1 and the Likelihood of Surviving Hepatocellular Carcinoma
HUI-TING HSU, YUEH-MIN LIN, MING-TAI HSING, KUN-TU YEH, JENG-WEI LU and SHUN-FA YANG

In Vivo May 2024, 38 (3) 1316-1324; DOI: https://doi.org/10.21873/invivo.13571

Main menu

User menu

Search

hepatocellular carcinoma

Pages